James D Pipkin

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
CYDEX PHARMACEUTICALS, INC.
2
6
3
3
3
3
2
4
3
1
2005
2006
2008
2009
2010
2011
2012
2013
2014
2017
MERCK & CO., INC.
1
1994
E. R. Squibb & Sons, Inc.
1
1986
NPS PHARMACEUTICALS, INC.
1
2000
MERCK SHARP & DOHME CORP.
1
1
1
1
2
1993
1994
1997
2011
2015
CYDEX, INC.
1
2004
SPECTRUM PHARMACEUTICALS, INC.
1
2014

Inventor Addresses

AddressDuration
LAWRENCE, KSAug 02, 07 - Aug 30, 07
LAWRENCE, KS, USJan 08, 09 - Jan 08, 09
Lawrence, KSNov 22, 94 - Jun 26, 07
Lawrence, KS, USMay 14, 09 - May 16, 24
Lenexa, KS, USDec 17, 09 - Dec 17, 09
New Brunswick, NJAug 07, 90 - Aug 07, 90

Technology Profile

Technology Matters
A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1
A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 51

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2024/0156,7662024INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME0
2024/0139,1372024Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same0
2023/0255,9192023COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN0
2023/0233,6382023COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME0
2022/0387,4442022COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROST0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.